Tanabe Pharma is one of two companies developing a treatment for EPP and XLP. Image credit: Guenter Albers / Shutterstock.com Tanabe Pharma America’s oral melanocortin-1 receptor (MC1R) agonist has ...
The integration involving ERAs represents the most comprehensive synthesis to date on ERA efficacy and safety in CKD populations. Credit: NMK-Studio via Shutterstock.com. A recent research study, ...
D3 Bio will begin a Phase I trial for patients with advanced solid tumours harbouring KRAS G12D mutations. Credit: Bohbeh creations / Shutterstock.com. D3 Bio has received the US Food and Drug ...
Insomnia seriously affects both physical and mental health. Credit: Tero Vesalainen / Shutterstock.com. Nxera Pharma has announced positive top-line results from its Phase III study of daridorexant ...
Atea showcased its Phase III HCV programme at JPM, positioning the regimen for test-and-treat adoption in 1,800 patients.
Adalyon’s CEO, Ulrik Zeuthen, notes that speech-based biomarkers can be used across several applications to optimise trial ...
The trial evaluated the pharmacodynamics, pharmacokinetics, tolerability, and safety of TLC-2716. Credit: Sai Thaw Kyar / Shutterstock.com. OrsoBio has announced the publication in Nature Medicine of ...
The trial evaluated epcoritamab as a monotherapy against R-GemOx, or BR. Credit: Stock-Asso / Shutterstock.com. Danish biotechnology company Genmab has announced top line results from the Phase III ...
Axsome Therapeutics has initiated the FORWARD Phase III trial evaluating AXS-14 for the management of fibromyalgia, with the ...
Ocugen’s AAV gene therapy, OCU410, has demonstrated its capacity to reduce geographic atrophy (GA)-associated lesion growth in the Phase II ArMaDa trial. Image credit: VectorsMarket via ...
QPS executive vice-president Derek Grimes. Credit: QPS Holdings / Business Wire. US-based contract research organisation QPS Holdings (QPS) has implemented a new clinical trial pharmacovigilance ...
In a paper published in Nature Scientific Reports, the UK Biobank was used to better understand how the risk of stroke is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback